(Q70823389)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536375%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

title

Complement activation by malignant B cells from patients with chronic lymphocytic leukaemia (CLL) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536375%20AND%20SRC:MED&resulttype=core&format=json

chronic lymphocytic leukemia

14 October 2019

main subject

1 reference

H V Marquart

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536375%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

K Grønbaek

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536375%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

B E Christensen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536375%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

S E Svehag

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536375%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

R G Leslie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536375%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

publication date

1 December 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536375%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

14 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536375%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536375%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536375%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

page(s)

575-581

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536375%20AND%20SRC:MED&resulttype=core&format=json

Expression of cell surface markers after human B lymphocyte activation

14 October 2019

cites work

1 reference

12 December 2020

Levels of complement regulatory proteins, CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies

1 reference

12 December 2020

Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody

1 reference

12 December 2020

Differentiation of chronic lymphocytic leukemia cells after in vitro treatment with Epstein-Barr virus or phorbol ester. I. Immunologic and morphologic studies

1 reference

12 December 2020

Immunoglobulins on the surface of lymphocytes. IV. Distribution in hypogammaglobulinemia, cellular immune deficiency, and chronic lymphatic leukemia

1 reference

12 December 2020

Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies

1 reference

12 December 2020

The isolation and characterization of the V-H domain from rabbit heavy chains of different a locus allotype

1 reference

12 December 2020

Hairy Cell Leukemia: Proliferation of a Cell with Phagocytic and B-Lymphocyte Properties

1 reference

12 December 2020

The immune response to phichi174 in man. IV. Primary and secondary antibody production in patients with chronic lymphatic leukaemia

1 reference

12 December 2020

Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis

1 reference

12 December 2020

Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells

1 reference

12 December 2020

Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells

1 reference

12 December 2020

C3-activating proteases on human lymphoblastoid cells superinfected with Epstein-Barr Virus

1 reference

12 December 2020

Differentiation Capacity and Other Properties of the Leukemic Cells of Chronic Lymphocytic Leukemia*

1 reference

12 December 2020

Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin

1 reference

12 December 2020

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

1 reference

12 December 2020

Factor I Deficiency and C3 Nephritic Factor: Immunochemical Findings and Association with Neisseria meningitidis Infection in Two Patients

1 reference

12 December 2020

Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2)

1 reference

12 December 2020

Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serum

1 reference

12 December 2020

Control of human B-lymphocyte replication. II. Transforming Epstein-Barr virus exploits three distinct viral signals to undermine three separate control points in B-cell growth

1 reference

12 December 2020

Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset

1 reference

12 December 2020

Expression of B cell activation antigens on normal and malignant B cells

1 reference

12 December 2020

Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro

1 reference

12 December 2020

Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment

1 reference

12 December 2020

Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia

1 reference

12 December 2020

The regulators of complement activation (RCA) gene cluster

1 reference

12 December 2020

Cell surface antigen CD5 is a marker for activated human B cells

1 reference

12 December 2020

Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation

1 reference

12 December 2020

Quantitative measurement of Fc receptor activity on human peripheral blood monocytes and the monocyte-like cell line, U937, by laser flow cytometry

1 reference

12 December 2020

Decreased expression of complement receptor type 2 (CR2) on neoplastic B cells of chronic lymphocytic leukaemia

1 reference

12 December 2020

The role of C3 in the immune response

1 reference

12 December 2020

Complement alternative pathway activation by chronic lymphocytic leukemia cells: its role in their hepatosplenic localization

1 reference

12 December 2020

10.1111/J.1365-2249.1995.TB03855.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8536375%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference